Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

5:55 PM - 6:00 PM ET

Closing
Speaker: Miccio, Joseph, MD - Penn State Hershey Medical Center, Hershey, PA
5:55 PM - 6:00 PM ET

Closing
Speaker: Gao, Hao, PhD - UT Southwestern Medical Center, Dallas, TX
5:55 PM - 6:00 PM ET

Closing
Speaker: Jegadeesh, Naresh, MD - Cook Radiation Oncology, Chicago, Il
6:10 PM - 6:15 PM ET

Closing
Speaker: Yu, Jennifer, MD, PhD - Cleveland Clinic, Cleveland, OH

Tuesday, September 29

12:00 AM - 12:05 AM ET

2 - Test 0520
Speaker: Curtin, Cher - ASTRO, Arlington, VA
8:00 AM - 8:12 AM ET

ESTRO Highlights
Speaker: Jereczek, Barbara, MD, PhD, Prof. - European Institute of Oncology and University of Milan, Milan, Lombardy
12:30 PM - 12:40 PM ET

243 - From Data to Dialogue: A Real-Time Digital Platform Accelerates Multidisciplinary Decisions in Bone Metastases
Speaker: Bedi, Manpreet, MD, MS - Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
12:30 PM - 12:40 PM ET

249 - A Randomized Phase II Study of Enhanced AR Blockade with Enzalutamide In High-Risk Patients with Biochemical Relapse Undergoing Salvage Radiation: Final Results from RTOG 3506 (STEEL)
Speaker: Posadas, Edwin, MD - Cedars-Sinai Medical Center, Los Angeles, CA
12:30 PM - 12:39 PM ET

255 - The HYPCON Trial 2: A Phase II Randomized Study Evaluating Hypofractionated vs. Conventional Adjuvant Concurrent Chemoradiation in Head and Neck Malignancies
Speaker: Ramadas, Aarcha, MBBS - AIIMS New Delhi, New Delhi, Delhi
12:30 PM - 12:40 PM ET

260 - Depletion of Alzheimer's-Associated Presenilin-1 Enhances Radiosensitivity of Hepatocellular Carcinoma
Speaker: Jia, Min-qi, PhD - Peking University Cancer Hospital, Beijing, Beijing
12:30 PM - 12:40 PM ET

266 - Time-Dependent Solution to the Van Herk PTV Margin Formalism for Brain, Head-and-Neck, Thorax, Breast, Abdomen and Pelvis Sites via 33,000 Image Pairs
Speaker: Pogue, Joel, PhD - University of Alabama at Birmingham, Birmingham, AL
12:30 PM - 12:40 PM ET

273 - A Prospective, Randomized Controlled Study on the Time Window of Radiotherapy Combined with Targeted Therapy for Primary Tumor in Stage IV NSCLC
Speaker: Hu, Cheng, MD - THE AFFILIATED HOSPITAL OF GUIZHOU MEDICAL UNIVERSITY, GuiYang